Today's therapy of functional gastrointestinal disorders - Does it help?

European Journal of Surgery, Supplement

Volumn 164, Issue 583, 1998, Pages 92-97

  Berstad, Arnold ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Functional dyspepsia; Gastric accommodation; Irritable bowel syndrome; Vagal tone

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; FEDOTOZINE; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; SUMATRIPTAN; BENZYL DERIVATIVE; CISAPRIDE; GASTROINTESTINAL AGENT; KAPPA OPIATE RECEPTOR; PROPYLAMINE;

ARTICLE; DIETARY FIBER; DYSPEPSIA; GASTROINTESTINAL DISEASE; IRRITABLE COLON; MENTAL STRESS; NEUROSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; VAGUS NERVE STIMULATION; CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; PATHOPHYSIOLOGY; REVIEW;

ANTACIDS; BENZYL COMPOUNDS; CISAPRIDE; CLINICAL TRIALS; COLONIC DISEASES, FUNCTIONAL; DYSPEPSIA; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; PROPYLAMINES; RECEPTORS, OPIOID, KAPPA;

EID: 0032216687     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Berstad A, Weberg R. Review. Antacids in the treatment of gastroduodenal ulcer. Scand J Gastroenterol 1986; 21: 385-391.
2. Berstad A, Hausken T, Gilja OH, et al. Review. Gastric accommodation in functional dyspepsia. Scand J Gastroenterol 1997; 32: 193-197.
3. Coffin B, Bouhassira D, Chollet R, Fraitag B, De Meynard C, Geneve J, Lemann M, Willer JC, Jian R. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996; 10: 919-925.
4. Dapoigny M, Abitbol JL, Fraitag B. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci 1995; 40: 2244-2249.
5. De Nutte N, van Ganse W, Witterhulghe M, Defrance P. Relief of gastric pain in non-ulcer dyspepsia: controlled trial of the promotility drug of cisapride. Clin Ther 1989; 11: 62-68.
6. Distrutti E, Soldevilla A, Azpiroz F, Malagelada J-R. Gastric mechanoreceptors' response characterized by computerized tensostat in humans. Gastroenterology 1996; 110: A657.
7. Drossman DA, Li S, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580.
8. Farup PG, Hovde O, Breder O. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? Scand J Gastroenterol 1995; 30: 829-832.
9. Farup PG, Wetterhus S, Osnes M, Rebo T, Moe B. Ranitidine effectively relieves symptoms in a subgroup of patients with functional dyspepsia. Scand J Gastroenterol 1997; 32: 755-759.
10. Fraitag B, Homerin M, Hecketsweiler P. Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994; 39: 1072-1077.
11. Gilja OH, Hausken T, Bang CJ, Berstad A. Effect of glyceryl trinitrate on gastric accomodation and symptoms in functional dyspepsia. Dig Dis Sci (in press).
12. Gilja OH, Hausken T, Wilhelmsen I, Berstad A. Impaired accomodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996; 41: 689-696.
13. Gotthard R, Bodemar G, Brodin U, Jonsson K-Å. Treatment with cimetidine, antacids, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7-18.
14. Goudie BM, McKenzie PE, Cipriano J, Griffin EM, Murray FE. Repeat prescribing of ulcer healing drugs in general practice - prevalence and underlying diagnosis. Aliment Pharmacol Ther 1996; 10: 147-150.
15. Grossman P, Svebak S. Respiratory sinus arrhythmia as an index of parasympathetic cardial control during active coping. Psychophysiology 1987; 24: 228-235.
16. Haug TT, Svebak S, Hausken T, Wilhelmsen I, Berstad A, Ursin H. Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia. Psychosomat Med 1994; 56: 181-186.
17. Haug TT, Wilhelmsen I, Berstad A, Ursin H. Psychological factors and somatic symptoms in functional dyspepsia. A comparison with duodenal ulcer and healthy controls. J Psychosomat Res 1994; 38: 281-291.
18. Haug TT, Wilhelmsen I, Ursin H, Berstad A. What are the real problems for patients with functional dyspepsia. Scand J Gastroenterol 1995; 30: 97-100.
19. Haug TT, Wilhelmsen I, Svebak S, Berstad A, Ursin H. Psychotherapy in functional dyspepsia. J Psychosomatic Res 1994; 38: 735-744.
20. Hausken T, Svebak S, Wilhelmsen I, et al. Low vagal tone and antral dysmotility in patients with functional dyspepsia. Psychosomat Med 1993; 55: 12-22.
21. Hausken T, Berstad A. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1992; 27: 213-217.
22. Hveem K, Svebak S, Hausken T, Berstad A. Effect of mental stress and cisapride on autonomic nerve functions in functional dyspepsia. Gastroenterology 1996; 110: A683.
23. Iovino P, Azpiroz F, Domingo E, Malagelada J-R. The sympathetic nervous system modulates perception and reflex responses to gut distention in humans. Gastroenterology 1995; 108: 680-686.
24. Jian R, Ducrot F, Ruskone A, et al. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34: 657-664.
25. Johannessen T, Fjøsne U, Kleveland PM, Halvorsen T, Kristensen P, Løge I, et al. The effect of cimetidine in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327-336.
26. Knuhtsen S, Hansen JM, Pedersen FM, Havelund T, Schaffalitzky de Muckadell OB. No effect of omeprazole in treatment of non-ulcer dyspepsia. Gut 1994; 35 (Suppl 4): A8-9.
27. Lauritsen K, Aalykke C, Havelund T, et al. Effect of omeprazole in functional dyspepsia; A double-blind randomized, placebo-controlled study. Gastroenterology 1996; 110: A702.
28. Leek BF. Abdominal visceral receptors. In: Autrum H, Jung R, Loewenstein WR, MacKay DM, Teuber HL (eds): Handbook of Sensory Physiology. Berlin, Heidelberg, New York; Springer-Verlag. 1972; III/1: 113-160.
29. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
30. Mowat C, Carswell A, Williams C, McColl KEL. Effect of omeprazole on intragastric concentrations of nitrite and ascorbic acid. Z Gastroenterol 1997; 35: 1108 (Abstract).
31. Myren J, Løvland B, Larssen SE, Larsen S. A double-blind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984; 19: 835-843.
32. Nesland Aa, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985; 20: 629-635.
33. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21: 953-956.
34. Notivol R, Coffin B, Azpiroz F, Mearin F, Serra J, Malagelada J-R. Gastric tone determines the sensitivity of the stomach to distension. Gastroenterology 1995; 108: 330-336.
35. Nyrén O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in npn-ulcer dyspepsia. N Engl J Med 1986; 314: 339-343.
36. Nyrén O, Adami HO, Bergstrøm R, Gustavsen F, Løøf L. Psychological factors are crucial in the etiology of non-ulcer dyspepsia. A population based case control study. In non-ulcer dyspepsia. Nyrén O (ed.) Acta Univ Uppsal 1985; 527: 1-34 (Thesis).
37. Roberts SJ, Bateman DN. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England. Aliment Pharmacol Ther 1995; 9: 137-143.
38. Rydning A, Berstad A, Berstad T, Hertzenberg L. The effect of guar gum and fiber-enriched wheat bran on gastric emptying of a semisolid meal in healthy subjects. Scand J Gastroenterol 1985; 20: 330-334.
39. Rydning A, Berstad A, Ådland E, Ødegaard B. Prophylactic effect of dietary fibre in duodenal ulcer disease. Lancet 1982; II: 736-739.
40. Swedlund H, Sjødin L, Ottosson JO, Doteval G. Controlled study of psychotherapy in irritable bowel syndrome. Lancet 1983; 2: 589-591.
41. 1 activation has a major impact on gastrointestinal functions in man. Gastroenterology 1996; 110: A1123.
42. Talley NJ, Owen BK, Boyce P, Paterson K. Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996; 91: 277-286.
43. Talley NJ. Review article: functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-115.
44. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin. Scand J Gastroenterol 1996; 31: 318-325.
45. Testoni PA, Bagnolo F, Fanti L, Passaretti S, Tittobello A. Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients. Gut 1990; 31: 286-290.
46. Thompson WG. Irritable bowel syndrome: pathogenesis and management. Lancet 1993; 341: 1569-1572.
47. Thors H, Sigurdsson H, Oddson E, Thjodleifsson B. Survey of prescriptions for peptic ulcer drugs (ACT Class A0B2) in Iceland. Scand J Gastroenterol 1994; 29: 988-994.
48. Ursin H. Expectancy, activation and somatic health: a new psychosomatic theory. In: Levine S, Ursin H (eds). Coping and Health. New York: Plenum Press, 1980.
49. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649-653.
50. Weberg R, Berstad A. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial. Scand J Gastroenterol 1988; 23: 237-243.
51. Whorwell PJ, Prior A, Farragher FB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet 1984; 2: 1232-1234.
52. Wilhelmsen I, Haug TT, Ursin H, Berstad A. Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer. Significance of somatization. Dig Dis Sci 1995; 40: 1105-1111.